Nuclear transport as a target for cancer therapies.
Henderson
Beric
B
Westmead Institute for Cancer Research, Westmead Millennium Institute, Darcy Road, Westmead, NSW 2145, Australia.
D021581:Active Transport, Cell Nucleus / Q000187:drug effects; D025601:Adenomatous Polyposis Coli Protein / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D015534:Trans-Activators / Q000378:metabolism*; D051176:beta Catenin
D025601:Adenomatous Polyposis Coli Protein; C495270:CTNNB1 protein, human; D003598:Cytoskeletal Proteins; D015534:Trans-Activators; D051176:beta Catenin